Study of Immunity-Boosting Measures and Hydroxychloroquine against Fight of COVID-19

According to the WHO dashboard, the Coronavirus disease of 2019 (COVID-19) had a global impact, with a total of 187,519,789 confirmed cases and 4,049,372 deaths as of July 14, 2021. Since its inception in December 2019, researchers have been seeking for ways to combat and overcome it, and as a result, preventive measures such as social separation of 3 feet, wearing a good face mask, and hand sanitization have become an unavoidable part of our daily routine. Immunity-enhancing techniques have also been advised to reduce the likelihood of becoming infected with the virus or, if already infected, to receive the milder form. In addition, the anti-inflammatory, antiviral, and immune-modulator medication hydroxychloroquine (HCQ) has been widely endorsed by many national advisory bodies, including India, as a preventative strategy and treatment against COVID-19 in the early stages of 2020. We’ve included information about immunity boosters and the role of HCQ in COVID-19.

Author (S) Details

Rashmi Singh
Department of Radiation Oncology, RIMS, Ranchi, Jharkhand, India.

Anup Kumar
Department of Radiation Oncology, RIMS, Ranchi, Jharkhand, India.

Rajanigandha Tudu
Department of Radiation Oncology, RIMS, Ranchi, Jharkhand, India.

Praveer Munda
Department of Radiation Oncology, RIMS, Ranchi, Jharkhand, India.

Payal Raina
Department of Radiation Oncology, RIMS, Ranchi, Jharkhand, India.

View Book :- https://stm.bookpi.org/NFMMR-V9/article/view/3468

Leave a Reply

Your email address will not be published. Required fields are marked *